Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease

Febuxostat is a nonpurine xanthine oxidase (XO) inhibitor, which recently received marketing approval. However, information regarding the experience with this agent among advanced chronic kidney disease (CKD) patients is limited. In the current study, we investigated the effects of oral febuxostat i...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Tetsu Akimoto (Autor), Yoshiyuki Morishita (Autor), Chiharu Ito (Autor), Osamu Iimura (Autor), Sadao Tsunematsu (Autor), Yuko Watanabe (Autor), Eiji Kusano (Autor), Daisuke Nagata (Autor)
Format: Knjiga
Izdano: AboutScience Srl, 2014-01-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno